Oxford Biomedica Plc (OXB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 128,797 | 89,539 | 139,989 | 142,797 | 87,728 |
| Cost of Goods | 75,776 | 49,812 | 70,808 | 60,157 | 41,655 |
| Gross Profit | 53,021 | 39,727 | 69,181 | 82,640 | 46,073 |
| Operating Expenses | 96,523 | 125,709 | 120,739 | 61,707 | 50,936 |
| Operating Income | -43,502 | -85,982 | -51,558 | 20,933 | -4,863 |
| Interest Expense | 10,505 | 11,199 | 8,754 | 888 | 912 |
| Other Income | 6,742 | -91,346 | 14,336 | -165 | -797 |
| Pre-tax Income | -47,265 | -188,527 | -45,976 | 19,880 | -6,572 |
| Income Tax | 1,344 | -4,365 | -817 | 869 | -327 |
| Net Income Continuous | -48,609 | -184,162 | -45,159 | 19,011 | -6,245 |
| Minority Interests | 5,419 | 26,672 | 6,002 | N/A | N/A |
| Net Income | $-43,190 | $-157,490 | $-39,157 | $19,011 | $-6,245 |
| EPS Basic Total Ops | -0.42 | -1.63 | -0.41 | 0.23 | -0.08 |
| EPS Basic Continuous Ops | -0.42 | -1.63 | -0.41 | 0.23 | -0.08 |
| EPS Diluted Total Ops | -0.42 | -1.63 | -0.41 | 0.22 | -0.08 |
| EPS Diluted Continuous Ops | -0.42 | -1.63 | -0.41 | 0.22 | -0.08 |
| EBITDA(a) | $-14,333 | $-148,618 | $-10,863 | $33,224 | $4,179 |